European Journal of Medicinal Chemistry · 2019 · 25 citations · 24 references
MedicineMedicinal ChemistryOncologyCell SignalingMolecular OncologySignal TransductionBreast Cancer PharmacotherapySignal Transduction In CancerTargeted Cancer TherapyTargeted TherapyTyrosine Kinase InhibitorsBreast Cancer ProgressionEgfr InhibitionEpidermal Growth Factor Receptor InhibitionPi3k InhibitorsTargeted Inhibitor Design
24
Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations
Medicine, Oncology, Pharmacology +17
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui et al. · Journal of Clinical Oncology · 2009 · 516 citations
Medicine, Oncology, Pharmacology +13
United States Food and Drug Administration Drug Approval Summary
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2004 · 500 citations
Medicine, Oncology, Pharmacology +15
FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets
Martin H. Cohen, John R. Johnson, Yeh‐Fong Chen et al. · The Oncologist · 2005 · 441 citations
Medicine, Oncology, Pharmacology +14